EDN1 and cancer: Our novel findings define a novel molecular mechanism involving interplay between microparticles, the ET-1 system and endothelial cell pro-inflammatory and redox signalling, which may be important in cardiovascular toxicity and hypertension in cancer patients treated with VEGFi.